Oncolytics Biotech's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Oncolytics Biotech (NASDAQ:ONCY) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.09. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $2.12 and has seen a 57.52% increase over the last 52-week period.
August 11, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Oncolytics Biotech is expected to report an EPS of $-0.09 in its upcoming earnings. The stock has seen a 57.52% increase over the last year and is currently trading at $2.12.
The upcoming earnings report is a significant event for Oncolytics Biotech. However, the company's past performance shows a mixed impact on the share price post-earnings release, making it difficult to predict the short-term impact. The stock has been performing well over the past year, which could potentially influence investor sentiment positively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100